Pharmena S.A. logo

Pharmena S.A. (PHR)

Market Closed
17 Jul, 14:50
WSE WSE
3. 15
0
0%
- Market Cap
- P/E Ratio
2.25% Div Yield
13 Volume
-2.32 Eps
3.15
Previous Close
Add Transaction
Day Range
3.15 3.15
Year Range
2.5 4.32
Want to track PHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PHR closed yesterday higher at zł3.15, an increase of 0% from Thursday's close, completing a monthly increase of 0% or zł0. Over the past 12 months, PHR stock gained 21.6216%.
The next announced payment will be in In 2 months on Oct 08, 2026 for a total of zł2.36.
The last earnings report, released on May 25, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0266%, based on the last three reports.
Pharmena S.A. has completed 4 stock splits, with the recent split occurring on Apr 12, 2019.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NYSE (USD).

PHR Chart

Are Investors Undervaluing Phreesia (PHR) Right Now?

Are Investors Undervaluing Phreesia (PHR) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 month ago
Phreesia, Inc. (PHR) Q1 2027 Earnings Call Transcript

Phreesia, Inc. (PHR) Q1 2027 Earnings Call Transcript

Phreesia, Inc. (PHR) Q1 2027 Earnings Call Transcript

Seekingalpha | 1 month ago
Phreesia Q1 Earnings Call Highlights

Phreesia Q1 Earnings Call Highlights

Phreesia NYSE: PHR reported higher first-quarter revenue and profitability for fiscal 2027, with executives pointing to growth in payment solutions, expanding opportunities from its AccessOne acquisition and continued investment in patient intake, provider engagement and artificial intelligence.

Marketbeat | 1 month ago

Pharmena S.A. (PHR) FAQ

What is the stock price today?

The current price is zł3.15.

On which exchange is it traded?

Pharmena S.A. is listed on WSE.

What is its stock symbol?

The ticker symbol is PHR.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.25%.

What is its market cap?

As of today, no market cap data is available.

Has Pharmena S.A. ever had a stock split?

Pharmena S.A. had 4 splits and the recent split was on Apr 12, 2019.

Pharmena S.A. Profile

Health Care Providers & Services Industry
Healthcare Sector
Chaim Indig CEO
WSE Exchange
PLPHRMN00011 ISIN
US Country
2,082 Employees
- Last Dividend
- Last Split
18 Jul 2019 IPO Date

Overview

Phreesia, Inc. operates as a technology-driven company focused on providing a comprehensive Software as a Service (SaaS)-based platform tailored for the healthcare industry within the United States and Canada. The company is dedicated to optimizing patient intake, enhancing the patient experience, and streamlining administrative processes for healthcare providers. With its inception in 2005 and headquartered in Wilmington, Delaware, Phreesia has established itself as a key player in digital healthcare solutions by furnishing a suite of services that addresses the intricacies of patient scheduling, registration, revenue cycle, and engagement through a versatile platform. Catering to a wide array of clients, including patients, single-specialty practices, multi-specialty groups, health systems, and companies in the pharmaceutical, medical device, and biotechnology sectors, Phreesia underscores its commitment to improving operational efficiencies and patient outcomes across the healthcare landscape.

Products and Services

  • Access Solutions

    Phreesia offers a sophisticated appointment scheduling system that is accessible online for all patients. This system enhances convenience by integrating reminders, thereby promoting punctuality and adherence to healthcare appointments. Additionally, its referral tracking management functionality optimizes the patient referral process, ensuring smooth transitions and communications between healthcare providers.

  • Registration Solution

    The company's registration solution revolutionizes patient self-registration by automating this critical process. This automation not only improves the accuracy of patient data collected but also significantly reduces administrative burdens on healthcare staff, leading to a more efficient and patient-centric registration experience.

  • Revenue Cycle Solution

    At the heart of Phreesia's offerings is a comprehensive solution designed to streamline the revenue cycle process. This includes advanced insurance verification processes to ensure accuracy and speed in patient billing, point-of-sale payment applications to facilitate convenient payment options at the time of service, post-visit payment collection mechanisms, and flexible payment plans to enhance affordability and payment compliance among patients.

  • Network Connect Solution

    This service delivers clinically relevant content directly to patients, enriching their healthcare experience by providing valuable information and insights related to their health and wellness. By integrating this solution, Phreesia fosters a more informed and engaged patient population, contributing positively to overall health outcomes.

Phreesia's platform versatility is demonstrated through its deployment in various modalities, such as Phreesia Mobile, which leverages the convenience and ubiquity of patients' mobile devices; Phreesia Dashboard, a web-based dashboard designed for healthcare services clients; PhreesiaPads, which are self-service intake tablets that streamline the check-in process; and Arrivals Kiosks, on-site kiosks that offer an alternative self-service registration option. These modalities underscore Phreesia's commitment to leveraging technology in augmenting the patient and provider experience in healthcare settings.

Contact Information

Address: 434 Fayetteville Street
Phone: 888 654 7473